PRESENTATION

Q3 FY2023 — Presentation

Q3 FY2023PDF · 17 pages820 KB
Fiscal Year 2023, Third Quarter
January 27, 2023
EARNINGS CALL
PRESENTATION

-- 1 of 17 --

2
HORACIO ROZANSKI
President and Chief Executive Officer
MATT CALDERONE
Chief Financial Officer
NATHAN RUTLEDGE
Director & Head of Investor Relations
CALL
PARTICIPANTS

-- 2 of 17 --

3
DISCLAIMER
Forward Looking Safe Harbor Statement
Certain statements contained in this presentation and in related comments by our management include “forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995. Examples of forward-looking statements include information concerning Booz Allen’s preliminary financial results, financial outlook and guidance, including
forecasted revenue, Adjusted EBITDA, Diluted EPS, Adjusted Diluted EPS, future quarterly dividends, and future improvements in operating margins, as well as any other statement that
does not directly relate to any historical or current fact. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “should,” “forecasts,”
“expects,” “intends,” “plans,” “anticipates,” “projects,” “outlook,” “believes,” “estimates,” “predicts,” “potential,” “continue,” “preliminary,” or the negative of these terms or other
comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will
prove to have been correct.
These forward-looking statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our
actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these
forward-looking statements. A number of important factors could cause actual results to differ materially from those contained in or implied by these forward-looking statements,
including those factors discussed in our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the fiscal year ended March 31, 2022,
which can be found at the SEC’s website at www.sec.gov. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the
foregoing cautionary statements. All such statements speak only as of the date made and, except as required by law, we undertake no obligation to update or revise publicly any forward-
looking statements, whether as a result of new information, future events or otherwise.
Note Regarding Non-GAAP Financial Data Information
Booz Allen discloses Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue,
Excluding Billable Expenses, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, Free Cash Flow Conversion, and Net Leverage Ratio, which are not recognized measurements
under accounting principles generally accepted in the United States, or GAAP, and when analyzing Booz Allen’s performance or liquidity as applicable, investors should (i) evaluate each
adjustment in our reconciliation of revenue to Revenue, Excluding Billable Expenses, operating income to Adjusted Operating Income, net income attributable to common stockholders to
Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income and Adjusted Diluted EPS, and net cash
used in operating activities to Free Cash Flow and Free Cash Flow Conversion, and net debt to Net Leverage Ratio and the explanatory footnotes regarding those adjustments, each as
defined under GAAP, (ii) use Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on
Revenue Excluding Billable Expenses, Adjusted Net Income, and Adjusted Diluted EPS in addition to, and not as an alternative to, revenue, operating income, net income attributable to
common stockholders or diluted EPS as measures of operating results, each as defined under GAAP, (iii) use Free Cash Flow, Free Cash Flow Conversion, and Net Leverage Ratio, in
addition to, and not as an alternative to, net cash used in operating activities as a measure of liquidity, each as defined under GAAP, and (iv) use Net Leverage Ratio in addition to, and not
as an alternative to, net debt as a measure of Booz Allen's debt leverage. The Appendix includes a reconciliation of Revenue, Excluding Billable Expenses, Adjusted Operating Income,
Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, Free
Cash Flow Conversion, and Net Leverage Ratio to the most directly comparable financial measure calculated and presented in accordance with GAAP. Booz Allen presents these
supplemental performance measures because it believes that these measures provide investors and securities analysts with important supplemental information with which to evaluate
Booz Allen’s performance, long term earnings potential, or liquidity, as applicable, and to enable them to assess Booz Allen’s performance on the same basis as management. These
supplemental performance and liquidity measurements may vary from and may not be comparable to similarly titled measures by other companies in Booz Allen’s industry. With respect
to our expectations under “Financial Outlook”, "Fiscal Year 2023 Operating Cash Bridge" and "Fiscal Year 2023 ADEPS Bridge," reconciliation of Adjusted Diluted EPS guidance, Adjusted
EBITDA, and Adjusted EBITDA Margin on Revenue to the closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to our inability
to predict our stock price, equity grants and dividend declarations with respect to Adjusted Diluted EPS, and our net income, net interest and other expenses with respect to Adjusted
EBITDA and Adjusted EBITDA Margin on Revenue, during the course of fiscal 2023. With respect to Adjusted Diluted EPS guidance, projecting future stock price, equity grants and
dividends to be declared would be necessary to accurately calculate the difference between Adjusted Diluted EPS and GAAP EPS as a result of the effects of the two-class method and
related possible dilution used in the calculation of EPS. Consequently, any attempt to disclose such reconciliation would imply a degree of precision that could be confusing or misleading
to investors. We expect the variability of the above charges to have an unpredictable, and potentially significant, impact on our future GAAP financial results. For the same reason, a
reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin on Revenue guidance for fiscal 2023 and 2025 and of Adjusted EBITDA guidance through fiscal 2025 to the closest
corresponding GAAP measures are not available without unreasonable efforts on a forward-looking basis due to our inability to predict specific quantifications of the amounts that would
be required to reconcile such measures. Accordingly, Booz Allen is relying on the exception provided by Item 10(e)(1)(i)(B) of Regulation S-K to exclude these reconciliations.

-- 3 of 17 --

4
KEY FINANCIAL RESULTS
THIRD QUARTER FISCAL YEAR 2023 RESULTS
(1) Comparisons are to prior fiscal year period.
(2) Reconciliations of Adjusted EBITDA and Adjusted EBITDA Margin on Revenue can be found on Slide 14. Net Income attributable to common stockholders was $31.0 million and $340.2 million for the three and nine months ended December 31, 2022.
Net income margin attributable to common stockholders was 1.4% and 5.0% for the three and nine months ended December 31, 2022.
THIRD QUARTER (1) FISCAL YEAR-TO-DATE (12/31/22) (1)
Revenue $2.3 billion +12.1% $6.8 billion +11.4%
Revenue, Excluding Billable Expenses $1.6 billion +11.2% $4.8 billion +10.4%
Net Income $31 million (76.2)% $340 million (9.6)%
Adjusted EBITDA2 $244 million +9.8% $783 million +7.2%
Adjusted EBITDA Margin on Revenue2 10.7% (1.8)% 11.5% (3.4)%
Adjusted Net Income $142 million +4.0% $471 million +4.0%
Diluted EPS $0.23 (75.8)% $2.54 (8.0)%
Adjusted Diluted EPS $1.07 +4.9% $3.55 +6.0%
Net Cash Provided by Operating Activities $139 million +547.4% $366 million (24.0)%

-- 4 of 17 --

5

-- 5 of 17 --

6
KEY FINANCIAL RESULTS
THIRD QUARTER FISCAL YEAR 2023 RESULTS
(1) Comparisons are to prior fiscal year period.
(2) Reconciliations of Adjusted EBITDA and Adjusted EBITDA margin on Revenue can be found on Slide 14. Net Income attributable to common stockholders was $31.0 million and $340.2 million for the three and nine months ended December 31, 2022.
Net income margin attributable to common stockholders was 1.4% and 5.0% for the three and nine months ended December 31, 2022.
THIRD QUARTER (1) FISCAL YEAR-TO-DATE (12/31/22) (1)
Revenue $2.3 billion +12.1% $6.8 billion +11.4%
Revenue, Excluding Billable Expenses $1.6 billion +11.2% $4.8 billion +10.4%
Net Income $31 million (76.2)% $340 million (9.6)%
Adjusted EBITDA2 $244 million +9.8% $783 million +7.2%
Adjusted EBITDA Margin on Revenue2 10.7% (1.8)% 11.5% (3.4)%
Adjusted Net Income $142 million +4.0% $471 million +4.0%
Diluted EPS $0.23 (75.8)% $2.54 (8.0)%
Adjusted Diluted EPS $1.07 +4.9% $3.55 +6.0%
Net Cash Provided by Operating Activities $139 million +547.4% $366 million (24.0)%
Page 4 intentionally repeated

-- 6 of 17 --

7
$22.0
HISTORICAL BACKLOG & BOOK-TO-BILL
(1) For more information on the components of backlog, and the differences between backlog and remaining performance obligations, please see the Company's Form 10-K for the fiscal year ended March 31, 2022; totals may not sum due to rounding.
(2) Backlog presented includes backlog acquired in the Company's acquisition of EverWatch during the three months ended December 31, 2022. Backlog presented includes approximately $273 million from EverWatch as of December 31, 2022.
BACKLOG ($ IN BILLIONS) (1)(2)
BOOK-TO-BILL TRENDS
$20.7 $23.0 	$24.6 	$23.3 	$24.0
$26.8 $29.0 	$27.8 	$29.2 	$28.6
$31.8 $30.0
$3.4 	$3.4 	$4.5 	$3.6 	$3.5 	$3.5 	$4.9 	$4.0 	$3.7 	$4.0 	$5.5 	$4.5
$4.5 	$4.7 $6.2 	$6.0 	$6.1 	$9.0 $9.5 	$9.4 	$9.9 	$10.0 	$10.4 	$10.1
$12.8 	$14.8 $13.9 	$13.7 	$14.4
$14.3 $14.6 	$14.3 	$15.6 	$14.6 $16.0 	$15.4
Funded 	Unfunded 	Priced Options
4Q20 	1Q21 	2Q21 	3Q21 	4Q21 	1Q22 	2Q22 	3Q22 	4Q22 	1Q23 	2Q23 	3Q23
0.38x
2.17x
1.77x
0.32x
1.38x 	1.30x
2.03x
0.39x
1.66x
0.72x
2.40x
0.09x
Quarterly Book-to-Bill 	LTM Book-to-Bill
4Q20 	1Q21 	2Q21 	3Q21 	4Q21 	1Q22 	2Q22 	3Q22 	4Q22 	1Q23 	2Q23 	3Q23
0.0x
1.0x
2.0x
3.0x
4.0x

-- 7 of 17 --

8
CAPITAL ALLOCATION
DELIVERING STRONG CAPITAL RETURNS THROUGH EFFICIENT CAPITAL DEPLOYMENT
STRATEGY
– Our multi-year capital deployment plan is to follow a disciplined and opportunistic approach, subject to market conditions
– In Q3 FY2023, we deployed approximately $510.2 million:
– $57.3 million through quarterly dividends;
– $10.8 million through share repurchases; and
– $442.1 million through our acquisition of EverWatch.
– The Board authorized a dividend of $0.47 per share payable on March 1, 2023 to stockholders of record on February 10, 2023
– Share repurchase authorization capacity is $965.2 million available as of December 31, 2022
– Our capital allocation priorities remain: operating needs, quarterly dividend, strategic M&A, share repurchases, and debt repayment
HISTORICAL CAPITAL DEPLOYMENT ($ IN MILLIONS)(1)
QUARTERLY CAPITAL DEPLOYMENT ($ IN MILLIONS)(1)
$138.8
$180.9
$116.5 $86.9
$510.2
$49.8 	$57.4 	$58.9 	$57.0 	$57.3
$82.8 $119.6 $57.6 $29.9 	$10.8
$6.2
$4.0
$— $—
$442.1
Quarterly Dividends 	Share Repurchases 	M&A
3Q22 	4Q22 	1Q23 	2Q23 	3Q23
$364.2 	$333.2
$571.3
$1,493.9
$894.5
$114.2 	$146.6 	$181.1 	$209.1 	$230.6
$250.0 	$186.6
$318.1 $419.3 $217.8
$72.2
$865.5
$446.1
Quarterly Dividends 	Share Repurchases 	M&A
FY19 	FY20 	FY21 	FY22 	LTM
(3)(4)
(1) Totals may not sum due to rounding.
(2) Includes share repurchases transacted but not settled and paid.
(3) Represents payments for strategic investments, net of cash acquired.
(4) Total amount of capital deployed for fiscal 2022 does not include ~$2 million in applicable fees related to our acquisition of Tracepoint.
(2) (3)(4) (2)

-- 8 of 17 --

9
FINANCIAL OUTLOOK
RAISING FULL YEAR FISCAL 2023 GUIDANCE1
OPERATING PERFORMANCE Updated
Fiscal 2023 Guidance Prior
Fiscal 2023 Guidance
Total Revenue Growth2 9.5% – 10.5% 8.0 – 10.0%
Adjusted EBITDA $995 – $1,015 million $975 – $1,015 million
Adjusted EBITDA Margin on Revenue High 10%-to-Low 11% High 10%-to-Low 11%
Adjusted Diluted EPS3 $4.35 – $4.50 $4.25 – $4.50
Net Cash Provided by Operating Activities4 $875 – $950 million $875 – $950 million
(1) Reconciliations omitted in reliance on Item 10(e)(1)(i)(B) of Regulation S-K. See "Disclaimer".
(2) Updated Fiscal 2023 Guidance includes approximately 2% of the targeted growth in revenue includes Liberty, Tracepoint and EverWatch, partially offset by the MENA and MTS divestitures.
(3) Updated Fiscal 2023 Guidance assumes an effective tax rate of 23–25%; average diluted shares outstanding of 131–133 million, and interest expense of $117-122 million.
(4) Excludes approximately $315 million of net cash taxes we expect to pay in fiscal 2023, as detailed on Slide 10.

-- 9 of 17 --

10
FISCAL YEAR 2023 OPERATING CASH BRIDGE
(1) Totals may not sum due to rounding.
(2) Adding back fiscal year 2022 cash tax payments to show an equal comparison to fiscal year 2023 Operating Cash Flow before cash tax payments.
(3) Reflects the expected impact of the midpoints of fiscal 2023 Adjusted EBITDA range of $995-1,015 million, interest expense range of $117-122 million, and effective tax rate range of 23-25 percent.
(4) Guidance reflects (i) cash taxes associated with tax law changes and strategic planning of $175 million, offset by (ii) a partial tax refund of $175 million received in October 2022 associated with prior strategic tax planning initiatives.
(5) Reflects the Company's refined estimate of cash to be paid in fiscal 2023 based upon current tax obligations relating to research and development expenditures.
Operating Cash
Bridge FY22 to FY23 Current Guidance1 Original Guidance1
FY22 Operating Cash $737 million $737 million
FY22 Net Cash Paid for Income
Taxes2 $(127) million $(127) million
Adjusted EBITDA Growth3 ~$60 – $80 million ~$40 – $80 million
Interest Expense3 ~$(26) million ~$(25) million
Net Changes in Working Capital ~$(23) – $33 million ~$(4) – $31 million
FY23 Operating Cash Excluding Net
Cash to be Paid for Income Taxes $875 - $950 million $875 - $950 million
Effective Tax Rate3 ~$(175) million ~$(175) million
Tax Law Changes & Strategic
Planning4 $— $—
Section 1745 ~$(140) million ~$(140) million
FY23 Operating Cash $560 - $635 million $560 - $635 million

-- 10 of 17 --

11
FISCAL YEAR 2023 ADEPS BRIDGE
ADEPS BRIDGE
FROM FY22 TO FY23 Updated Guidance1 Original Guidance1
FY22 ADEPS $4.21 $4.21
Revenue Growth ~$0.51 – $0.56 ~$0.43 – $0.53
Adjusted EBITDA Margin ~$(0.15) – $(0.05) ~$(0.19) – $(0.05)
FY23 Operational ADEPS $4.57 – $4.72 $4.45 – $4.70
Depreciation and Amortization2 ~$(0.03) ~$(0.03)
Interest Expense3 ~$(0.15) ~$(0.14)
Income Tax Expense4 ~$(0.06) ~$(0.06)
Other Below-the-Line Items5 ~$0.02 ~$0.04
FY23 ADEPS $4.35 – $4.50 $4.25 – $4.50
(1) Totals may not sum due to rounding.
(2) Reflects the incremental increase in depreciation and amortization related to investments in infrastructure and technology.
(3) Reflects the midpoint of the fiscal 2023 estimated interest expense range as compared to fiscal 2022 results.
(4) Reflects the midpoint of the fiscal 2023 estimated effective tax rate range as compared to fiscal 2022 results.
(5) Reflects the estimated interest income and lower average diluted shares outstanding from fiscal 2022 to fiscal 2023.

-- 11 of 17 --

12
APPENDIX

-- 12 of 17 --

13
NON-GAAP FINANCIAL INFORMATION
• "Revenue, Excluding Billable Expenses" represents revenue less billable expenses. We use Revenue, Excluding Billable Expenses because it
provides management useful information about the Company's operating performance by excluding the impact of costs that are not indicative of
the level of productivity of our client staff headcount and our overall direct labor, which management believes provides useful information to our
investors about our core operations.
• "Adjusted Operating Income" represents operating income before acquisition and divestiture costs, financing transaction costs, significant
acquisition amortization, and the reserve associated with the U.S. Department of Justice investigation disclosed in Note 15 to the Condensed
Consolidated Financial Statements in the Company's Form 10-Q for the period ended December 31, 2022. We prepare Adjusted Operating Income
to eliminate the impact of items we do not consider indicative of ongoing operating performance due to their inherent unusual, extraordinary, or
non-recurring nature or because they result from an event of a similar nature.
• "Adjusted EBITDA" represents net income attributable to common stockholders before income taxes, net interest and other expense and
depreciation and amortization and before certain other items, including acquisition and divestiture costs, financing transaction costs, and the
reserve associated with the U.S. Department of Justice investigation disclosed in Note 15 to the Condensed Consolidated Financial Statements in
the Company's Form 10-Q for the period ended December 31, 2022. “Adjusted EBITDA Margin on Revenue” is calculated as Adjusted EBITDA
divided by revenue. Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses is calculated as Adjusted EBITDA divided by Revenue,
Excluding Billable Expenses. We prepare Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, and Adjusted EBITDA Margin on Revenue,
Excluding Billable Expenses to eliminate the impact of items we do not consider indicative of ongoing operating performance due to their inherent
unusual, extraordinary or non-recurring nature or because they result from an event of a similar nature.
• "Adjusted Net Income" represents net income attributable to common stockholders before: (i) acquisition and divestiture costs, (ii) financing
transaction costs, (iii) significant acquisition amortization, (iv) the reserve associated with the U.S. Department of Justice investigation disclosed in
Note 15 to the Condensed Consolidated Financial Statements in the Company's Form 10-Q for the period ended December 31, 2022, (v) gain
associated with equity method investment activity, (vi) gain associated with divestitures or deconsolidation, and (vii) amortization and write-off of
debt issuance costs and debt discount, in each case net of the tax effect where appropriate calculated using an assumed effective tax rate. We
prepare Adjusted Net Income to eliminate the impact of items, net of tax, we do not consider indicative of ongoing operating performance due to
their inherent unusual, extraordinary, or non-recurring nature or because they result from an event of a similar nature. We view Adjusted Net
Income as an important indicator of performance consistent with the manner in which management measures and forecasts the Company's
performance and the way in which management is incentivized to perform.
• "Adjusted Diluted EPS" represents diluted EPS calculated using Adjusted Net Income as opposed to net income. Additionally, Adjusted Diluted EPS
does not contemplate any adjustments to net income as required under the two-class method as disclosed in the footnotes to our consolidated
financial statements in our Form 10-K for the fiscal year ended March 31, 2022.
• "Free Cash Flow" represents the net cash generated from operating activities less the impact of purchases of property, equipment and software.
"Free Cash Flow Conversion" is calculated as Free Cash Flow divided by Adjusted Net Income.
• "Net Leverage Ratio" is calculated as net debt (total debt less cash) divided by Adjusted EBITDA over the prior twelve months.

-- 13 of 17 --

14
NON-GAAP FINANCIAL INFORMATION (Unaudited)
Three Months Ended December 31, Nine Months Ended December 31,
(In thousands, except share and per share data) 2022 2021 2022 2021
Revenue, Excluding Billable Expenses
Revenue $ 2,277,074 $ 2,030,520 $ 6,825,650 $ 6,125,624
Less: Billable expenses 710,526 621,550 2,069,733 1,817,215
Revenue, Excluding Billable Expenses $ 1,566,548 $ 1,408,970 $ 4,755,917 $ 4,308,409
Adjusted Operating Income
Operating income $ 58,640 $ 177,212 $ 489,756 $ 536,836
Acquisition and divestiture costs (a) 19,096 5,346 40,121 85,815
Financing transaction costs (b) — — 6,888 2,348
Significant acquisition amortization (c) 14,101 11,884 36,275 26,410
Legal matter reserve (d) 124,000 — 124,000 —
Adjusted Operating Income $ 215,837 $ 194,442 $ 697,040 $ 651,409
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue & Adjusted EBITDA Margin on
Revenue, Excluding Billable Expenses
Net income attributable to common stockholders 30,997 128,931 $ 340,213 $ 375,867
Income tax expense 10,539 30,090 103,286 103,569
Interest and other, net (e) 17,412 18,276 46,907 57,485
Depreciation and amortization 42,046 39,576 121,200 104,923
EBITDA 100,994 216,873 611,606 641,844
Acquisition and divestiture costs (a) 19,096 5,346 40,121 85,815
Financing transaction costs (b) — — 6,888 2,348
Legal matter reserve (d) 124,000 — 124,000 —
Adjusted EBITDA $ 244,090 $ 222,219 $ 782,615 $ 730,007
Net income margin attributable to common stockholders 1.4 % 6.3 % 5.0 % 6.1 %
Adjusted EBITDA Margin on Revenue 10.7 % 10.9 % 11.5 % 11.9 %
Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses 15.6 % 15.8 % 16.5 % 16.9 %
Adjusted Net Income
Net income attributable to common stockholders $ 30,997 $ 128,931 $ 340,213 $ 375,867
Acquisition and divestiture costs (a) 19,096 5,346 40,121 85,815
Financing transaction costs (b) — — 6,888 2,348
Significant acquisition amortization (c) 14,101 11,884 36,275 26,410
Legal matter reserve (d) 124,000 — 124,000 —
Gain associated with equity method investment activity (f) — (7,095) — (12,761)
Gains associated with divestitures or deconsolidation (g) (13,472) — (44,632) —
Amortization and write-off of debt issuance costs and debt discount 780 821 5,780 2,524
Adjustments for tax effect (h) (33,020) (2,848) (37,518) (27,127)
Adjusted Net Income $ 142,482 $ 137,039 $ 471,127 $ 453,076
Adjusted Diluted Earnings Per Share
Weighted-average number of diluted shares outstanding 132,759,877 134,262,250 132,831,569 135,314,226
Diluted earnings per share $ 0.23 $ 0.95 $ 2.54 $ 2.76
Adjusted Net Income Per Diluted Share (i) $ 1.07 $ 1.02 $ 3.55 $ 3.35
Free Cash Flow
Net cash provided by operating activities $ 138,582 $ 21,405 $ 365,674 $ 481,151
Less: Purchases of property, equipment and software (21,664) (21,933) (51,398) (51,608)
Free cash flow $ 116,918 $ (528) $ 314,276 $ 429,543
Operating cash flow conversion 447 % 17 % 107 % 128 %
Free cash flow conversion 82 % — % 67 % 95 %
14

-- 14 of 17 --

15
NON-GAAP FINANCIAL INFORMATION (Unaudited)
15
(a) Represents costs associated with the acquisition efforts of the Company related to transactions for which the Company has entered into a letter of
intent to acquire a controlling financial interest in the target entity, as well as the divestiture costs incurred in divesting a portion of our business.
Acquisition and divestiture costs primarily include costs associated with (i) buy-side and sell-side due diligence activities, (ii) compensation expenses
associated with employee retention, and (iii) legal and advisory fees primarily associated with the acquisitions of Liberty IT Solutions, LLC
(“Liberty”) and Tracepoint Holdings, LLC (“Tracepoint”) in fiscal 2022, and the acquisition of EverWatch Corp. (“EverWatch”) and the divestitures of
our management consulting business serving the Middle East and North Africa (“MENA”) and our Managed Threat Services business ("MTS") in
fiscal 2023.
(b) Reflects expenses associated with debt financing activities incurred during the first quarter of fiscal 2022 and second quarter of fiscal 2023.
(c) Amortization expense associated with acquired intangibles from significant acquisitions. Significant acquisitions include acquisitions which the
Company considers to be beyond the scope of our normal operations. Significant acquisition amortization includes amortization expense
associated with the acquisition of Liberty in the first quarter of fiscal 2022 and the acquisition of EverWatch in the third quarter of fiscal 2023.
(d) Reserve associated with the U.S. Department of Justice's investigation of the Company. See Note 15, “Commitments and Contingencies,” to the
condensed consolidated financial statements for further information.
(e) Reflects the combination of Interest expense and Other income, net from the condensed consolidated statement of operations.
(f) Represents a gain in the second quarter of fiscal 2022 associated with the Company's remeasurement of its previously held equity method
investment in Tracepoint, and a gain in the third quarter of fiscal 2022 associated with the divestiture of a controlling financial interest in
SnapAttack.
(g) Represents the gain recognized on the divestitures of the Company's MENA business in the second quarter of fiscal 2023, its MTS business in the
third quarter of fiscal 2023, and the gain on the deconsolidation of an artificial intelligence software platform business in the third quarter of fiscal
2023.
(h) Reflects the tax effect of adjustments at an assumed effective tax rate of 26%, which approximates the blended federal and state tax rates, and
consistently excludes the impact of other tax credits and incentive benefits realized. The tax effect of certain discrete items is calculated specifically
and may vary from the general 26% rate.
(i) Excludes adjustments of approximately $0.5 million and $2.6 million of net earnings for the three and nine months ended December 31, 2022,
respectively, and $0.9 million and $2.4 million of net earnings for the three and nine months ended December 31, 2021, respectively, associated
with the application of the two-class method for computing diluted earnings per share.

-- 15 of 17 --

16
NON-GAAP FINANCIAL INFORMATION (Unaudited)
(In thousands, except share and per share data) Three Months Ended
December 31, 2022 Three Months Ended
September 30, 2022 Three Months Ended
June 30, 2022 Three Months Ended
March 31, 2022
Net income attributable to common stockholders $ 30,997 $ 170,932 $ 138,284 $ 90,795
Income tax expense 10,539 51,258 41,489 33,897
Interest and other, net (a) 17,412 1,882 27,613 23,653
Depreciation and amortization 42,046 39,052 40,102 40,824
EBITDA $ 100,994 $ 263,124 $ 247,488 $ 189,169
Acquisition and divestiture costs (b) 19,096 15,932 5,093 11,670
Financing transaction costs (c) — 6,888 — —
Legal matter reserve (d) 124,000 — — —
Restructuring costs (e) — — — 4,164
Adjusted EBITDA $ 244,090 $ 285,944 $ 252,581 $ 205,003
Last 12 months Adjusted EBITDA $ 987,618
Total Debt $ 2,821,711
Less: Cash 370,939
Net Debt $ 2,450,772
Net Leverage Ratio (f) 2.5
Three Months Ended
December 31, 2021 Three Months Ended
September 30, 2021 Three Months Ended
June 30, 2021 Three Months Ended
March 31, 2021
Net income attributable to common stockholders $ 128,931 $ 154,834 $ 92,102 $ 199,179
Income tax expense (benefit) 30,090 46,127 27,352 (48,937)
Interest and other, net (a) 18,276 17,406 21,803 20,765
Depreciation and amortization 39,576 37,602 27,745 21,455
EBITDA $ 216,873 $ 255,969 $ 169,002 $ 192,462
Acquisition and divestiture costs (b) 5,346 13,680 66,789 411
Financing transaction costs (c) — — 2,348 —
Adjusted EBITDA $ 222,219 $ 269,649 $ 238,139 $ 192,873
Last 12 months Adjusted EBITDA $ 922,880
Total Debt $ 2,816,271
Less: Cash 642,709
Net Debt $ 2,173,562
Net Leverage Ratio (f) 2.4
16
(a) Reflects the combination of Interest
expense and Other income, net from the
condensed consolidated statement of
operations.
(b) Represents costs associated with the
acquisition efforts of the Company related
to transactions for which the Company has
entered into a letter of intent to acquire a
controlling financial interest in the target
entity, as well as the divestiture costs
incurred in divesting a portion of our
business. Acquisition and divestiture costs
primarily include costs associated with (i)
buy-side and sell-side due diligence
activities, (ii) compensation expenses
associated with employee retention, and
(iii) legal and advisory fees primarily
associated with the acquisitions of Liberty
and Tracepoint in fiscal 2022, and the
acquisition of EverWatch and the
divestitures of our MENA business and MTS
business in fiscal 2023.
(c) Reflects expenses associated with debt
financing activities incurred during the first
quarter of fiscal 2022 and the second
quarter of fiscal 2023.
(d) Reserve associated with the U.S.
Department of Justice's investigation of the
Company. See Note 15, "Commitments and
Contingencies," to the condensed
consolidated financial statements for
further information.
(e) Reflects restructuring charges of $8.3
million incurred during the fourth quarter
of fiscal 2022, net of approximately $4.2
million of revenue recognized on
recoverable expenses, associated with
severance costs of a restructuring plan to
reduce certain executive administrative
personnel costs.
(f) "Net Leverage Ratio" is calculated as
net debt (total debt less cash) divided by
Adjusted EBITDA over the prior twelve
months.

-- 16 of 17 --

17
FINANCIAL RESULTS – KEY DRIVERS
Third Quarter Fiscal 2023 – Below is a summary of the key factors driving results for the fiscal 2023 third quarter ended December 31,
2022 as compared to the prior year period:
• Revenue increased 12.1% to $2.3 billion and Revenue, Excluding Billable Expenses increased 11.2% to $1.6 billion. Revenue growth
was primarily driven by a combination of headcount growth, salary increases, and strong demand for our solutions, as well as higher
staff utilization as compared to the prior year period. The increase in revenue also includes approximately $28.6 million of
contributions related to the Company's acquisition of EverWatch in the third quarter of fiscal 2023.
• Operating income decreased 66.9% to $58.6 million and Adjusted Operating Income increased 11.0% to $215.8 million. Operating
income was negatively impacted by a $124.0 million reserve associated with the U.S. Department of Justice's investigation of the
Company recorded in the third quarter of fiscal 2023, as well as less favorable contract mix, higher unallowable spending, higher
billable expense mix and inflationary pressures, partially offset by strong contract-level performance. The increase in Adjusted
Operating Income was driven by the same factors impacting Operating Income with the exception of the aforementioned legal matter
reserve, which did not impact Adjusted Operating Income.
• Net income decreased 76.2% to $30.7 million, and net income attributable to common stockholders decreased 76.0% to $31.0
million. These changes were primarily driven by the same factors as operating income, as well as higher interest expense, partially
offset by a net gain of $8.9 million from the de-consolidation of an artificial intelligence software platform business, and a $4.6
million pre-tax gain associated with the divestiture of the Company's Managed Threat Services business. Adjusted Net income
increased 4.0% to $142.5 million. The change in Adjusted Net Income was primarily driven by the same factors as Adjusted Operating
Income, as well as higher income tax expense.
• EBITDA decreased 53.4% to $101.0 million and Adjusted EBITDA increased 9.8% to $244.1 million.These changes were due to the
same factors as operating income and Adjusted Operating Income, respectively.
• Diluted EPS decreased to $0.23 from $0.95 and Adjusted Diluted EPS increased to $1.07 from $1.02. The changes were primarily
driven by the same factors as Net Income and Adjusted Net Income, respectively, as well as a lower share count in the second quarter
of fiscal 2023.
• Net cash provided by operating activities was $138.6 million for the quarter ended December 31, 2022, as compared to $21.4 million
in the prior year period. Free Cash Flow was $116.9 million for the three months ended December 31, 2022, as compared to $(0.5)
million in the prior year period. The increase in net cash provided by operating activities was primarily driven by collections from
revenue growth and a net benefit from cash taxes paid during the quarter, partially offset by acquisition and divestiture related costs
paid during the third quarter of fiscal 2023.

-- 17 of 17 --